ABT – Market expectations are for record-high Uniform ROA, but management’s concerns about FX tailwinds and their Alinity systems imply this may be unwarranted

October 30, 2017

  • Abbott Laboratories (ABT:USA) currently trades near historical highs relative to UAFRS-based (Uniform) Earnings, with a 27.3x Uniform P/E, implying bullish expectations for the firm. However, given management’s concerns about FX tailwinds and their Alinity systems, this may be unwarranted
  • Specifically, management appears concerned about the sustainability of FX tailwinds, and the potential of their European Alinity systems launch. Should the firm fail to drive Uniform Margins back to pre-spinoff levels, as management sentiment suggests, multiple compression and equity downside would be warranted

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683